Are there advantages with U-Albumin/U-Creatinine ratios compared with U-Albumin in monitoring diabetes?

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 65, Issue 6, 2005, Pages 439-446

  Kallner, Anders ^a   Estonius, M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Albumin creatinine ratio; Microalbuminuria; Uncertainty in measurements

Indexed keywords

ALBUMIN; CREATININE;

ARTICLE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE MARKER; FEMALE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; LABORATORY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PERFORMANCE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; RATING SCALE; SENSITIVITY AND SPECIFICITY; STANDARD; SWEDEN; URINALYSIS; URINARY EXCRETION;

EID: 27144488174     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510510025700     Document Type: Article

References (18)

1. http://www.uib.no/isf/noklus/skup/#rapport #200218. Visited 04-12.
2. Risberg A, Larsson A, Olsson K, Lyrenäs S, Sjöqvuist M. Relationship between urinary albumin and albumin/creatinine ratio during normal pregnancy and pre-eclampsia. Scand J Clin Lab Invest 2004;64:17-23.
3. http://www.westgard.com/guest26.htm. Visited 04 12.
4. Bakker AJ. Detection of microalbuminuria. Diabetes Care 1999;22:307-13.
5. Catling W, Knight C, Mullee MA, Hill RD. Microalbuminuria in diabetes: a population study of the prevalence and an assessment of three screening tests. Diabet Med 1988;5:343-7.
6. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002;39 Suppl 1:1-266.
7. American Diabetes Association. Diabetic nephropathy. Diabetes Care 2003;26 Suppl 1:94-8.
8. Howey JE, Browning MC, Fraser CG. Biological variation of urinary albumin: consequences for analysis, specimen collection, interpretation of results, and screening programs. Am J Kidney Dis 1989;13:35-7.
9. Derhasching U, Kittler H, Woisetschläger C, Bur A, Herkner H, Hirschl MM. Microalbumin measurement alone or calculation of the albumin/creatinine ratio for the screening of hypertension patients. Nephrol Dial Transplant 2002;17:81-5.
10. Davidson MB, Bazargan M, Bakris G, Peters Harmel A, Campese V, Basta E. Immunodip: an improved screening method for microalbuminuria. Am J Nephrol 2004;24:284-8.
11. Jagenburg R, Berg B, Hellsing K, Kallner A. Protocol for the evaluation of reagent sets (chemicals and instruments) with special reference to "SPOT" tests' IFCC WG for rational use of urinary test strips. Uppsala J Med Sci 1986;91:225-7.
12. Hyltoft Petersen P, Sandberg S, Fraser CG, Goldschmidt H. A model for setting analytical quality specifications and design of control for measurements of the ordinal scale. Clin Chem Lab Med 2000;36:545-51.
13. BIMP, IEC, IFCC, ISO, IUPAC, IUPAP, OIML Guide to the expression of uncertainty in measurement. Geneva: ISO; 1993. ISBN 92-67-10188-9.
14. Kragten J. Calculation of standard deviations and confidence intervals with a universally applicable spreadsheet technique. Analyst 1994;119:2161-6.
15. Kallner A. Quality specifications based on the analysis of measurement. Scand J Clin Lab Invest 1999;59:513-7.
16. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM. Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;48:436-72.
17. 1-antitrypsin. Scand J Clin Lab Invest 1996;56:691-700.
18. Heymsfield SB, Arteage C, McManus C, Smith J, Moffitt S. Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr 1983;37:478-94.